45 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信90 3"

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

15668 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter University of Zurich

Microsoft Word - 05_2007101800709203_FullPaper_查.doc

... optical properties model (PROSPECT) was coupled with a 3-D canopy model (FLIGHT). PROSPECT idealizes the ... corresponding with specifications of CHRIS in Mode 3 (land). CHRIS aboard PROBA (Project for On-board Autonomy ... optical properties model (PROSPECT) was coupled with a 3-D canopy model (FLIGHT). PROSPECT idealizes the ... corresponding with specifications of CHRIS in Mode 3 (land). CHRIS aboard PROBA (Project for On-board Autonomy ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc ...

Synthese von 3,3-Dimethylperhydro-1,4-diazepin-2,5,7-trionen aus 3-...

... -oxazolin-5-ones are intermediates in the selective cleavage of the terminal amide function of 6 (Scheme 3 ... intermediates in the selective cleavage of the terminal amide function of 6 (Scheme 3 ) . 9 citations in Scopus ... Synthese von 3,3-Dimethylperhydro-1,4-diazepin-2,5,7-trionen aus 3-Dimethylamino-2,2-dimethyl-2H ... Synthese von 3,3-Dimethylperhydro-1,4-diazepin-2,5,7-trionen aus 3-Dimethylamino-2,2-dimethyl-2H ... Synthese von 3,3-Dimethylperhydro-1,4-diazepin-2,5,7-trionen aus 3-Dimethylamino-2,2-dimethyl-2H ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

782 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter University Hospital Zurich​, Research and Education Office

Slide S III 3

... : E85.4† I43.1* S III 3 Frau, 90 J., Tod an Bronchopneumonie. Keine bekannte Herzkrankheit ... herdförmige Amyloidablagerung um einzelne Fettgewebszellen 90-year-old female, death due to ... : E85.4† I43.1* S III 3 weitere Informationen auf HiPaKu   Frau, 90 J., Tod an Bronchopneumonie. Keine ... Slide S III 3 ... Slide S III 3 ...

Microsoft Word - CV_Friederike_Haslbeck_202003_English_ 3 seiten.docx

... Microsoft Word - CV_Friederike_Haslbeck_202003_English_ 3 seiten.docx Dr. rer. medic. Friederike B ... Medicine & Child Neurology, 60( 3), 217. https://doi.org/10.1111/dmcn.13677 Haslbeck, F.B., & Bassler, D ... Microsoft Word - CV_Friederike_Haslbeck_202003_English_ 3 seiten.docx ... Microsoft Word - CV_Friederike_Haslbeck_202003_English_ 3 seiten.docx Dr. rer. medic. Friederike B ... Microsoft Word - CV_Friederike_Haslbeck_202003_English_ 3 seiten.docx ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

7096 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter ETH Entrepreneurship

ETH_LearnTeachFair18_Journal_L06.indd

... Interactive Learning (Collaboration) Non-Disciplinary Competences Peer Review Research-Oriented Learning 3 ... . Procedia-Social and Behavioral Sciences, 21, 3-9. SAILER, C., KIEFER, P. & RAUBAL, M. 2015. An integrated ... 1- 3-PB.pdf ... https://www.learningteaching.ethz.ch/index.php/lt-eth/issue/download/1/ 3 ... 1- 3-PB.pdf ...

Research Highlights | Page 3 of 3

... Research Highlights | Page 3 of 3 ... https://www.demellogroup.ethz.ch/news/categories/research-highlights/page/ 3 ... Research Highlights | Page 3 of 3 ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

279 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Blutspende SRK Zürich

Unbenannt-3

... Unbenannt- 3 Multi-ethnic Lewis phenotype prediction using PCR-SSP genotyping on FUT2 and FUT3 ... ) Soejima et al., (2009); (2) Matzhold et al., 2009; ( 3) Pang et al., 1998; (4) Corvelo et al., 2013; (5 ... Unbenannt- 3 ... Unbenannt- 3 Multi-ethnic Lewis phenotype prediction using PCR-SSP genotyping on FUT2 and FUT3 ... Unbenannt- 3 ...

Microsoft PowerPoint - 2011-GASSNER-JAK2-clustering-e12-DGTI-Hannov...

... Microsoft PowerPoint - 2011-GASSNER-JAK2-clustering-e12-DGTI-Hannover ( 3).ppt Introduction and ... major allelic groups (clusters) of JAK2 exon 12 mutant alleles were made detectable (Figure 3 and 4 ... Microsoft PowerPoint - 2011-GASSNER-JAK2-clustering-e12-DGTI-Hannover ( 3).ppt ... Microsoft PowerPoint - 2011-GASSNER-JAK2-clustering-e12-DGTI-Hannover ( 3).ppt Introduction and ... Microsoft PowerPoint - 2011-GASSNER-JAK2-clustering-e12-DGTI-Hannover ( 3).ppt ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

32058 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Somagenetix

Some problems in research work of combined traditional Chinese and ...

... 要 看的页面不存在,请尝试以下操作: 1、如果您已经在地址栏中输入该网页的地址,请确认其拼写正确。 2、单击 后退 按钮,尝试其他链接。 3、打 网站主页,然后 找指向您感兴趣 的链接。 4、联系 ... Additional indexing Other titles: 您要 看的页面不存在,请尝试以下操作: 1、如果您已经在地址栏中输入该网页的地址,请确认其拼写正确。 2、单击 后退 按钮,尝试其他链接。 3、打 ... 网站主页,然后 找指向您感兴趣 的链接。 4、联系网站管理员,报告您访问的错误链接,我们将及时修正。 Item Type: Journal Article, refereed, original ...

Quantification of sodium T1 in abdominal tissues at 3 T - Zurich Op...

... ; flip angle = 90°; bandwidth = 450 Hz/px; voxel size = 5 × 5 × 10 mm$^{ 3}$). Variable T1-weighting was ... ; voxel size = 5 × 5 × 10 mm$^{ 3}$). Variable T1-weighting was achieved applying non-selective saturation ... volunteers (TR/TE = 858-928/1.57 ms; flip angle = 90°; bandwidth = 450 Hz/px; voxel size = 5 × 5 × 10 mm$^{ 3 ... Quantification of sodium T1 in abdominal tissues at 3 T - Zurich Open Repository and Archive ... Quantification of sodium T1 in abdominal tissues at 3 T - Zurich Open Repository and Archive ...

Mehr Ergebnisse

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

119 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Bio-Technopark Schlieren-Zürich

Allergan and Molecular Partners Present Late-Breaking Data from Pha...

... the pooled Phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week ... News Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of ... the pooled Phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week ... Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational ... Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational ...

Encouraging Additional Phase 3 Data Presented for Abicipar, and Sta...

... phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week abicipar, 12 ... News Encouraging Additional Phase 3 Data Presented for Abicipar, and Start of Phase 1 Trial for ... phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week abicipar, 12 ... Encouraging Additional Phase 3 Data Presented for Abicipar, and Start of Phase 1 Trial for MP0310 ... Encouraging Additional Phase 3 Data Presented for Abicipar, and Start of Phase 1 Trial for MP0310 ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2171 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Roche Glycart AG

Control B Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers

... 3 Bio", "DisclaimerGroup1": null, "ControlTissue": [ "" ], "BrandName": "Control B Level 3 Bio ... ": [ { "MaterialNum": "06682588001", "MaterialDescription": "Control B Level 3 Bio", "RegisteredProductName": "Control ... Control B Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers ... https://custombiotech.roche.com/global/en/products/cb/control-b-level- 3-bio-38101222.html ... Control B Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers ...

Control F Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers

... ", "DisclaimerGroup2": null, "ProductNameGlobal": "Control F Level 3 Bio", "DisclaimerGroup1": "Non-IVD ... ", "ControlTissue": [ "" ], "BrandName": "Control F Level 3 Bio", "LicenseDisclaimers": [ ], "Isotypes ... Control F Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers ... https://custombiotech.roche.com/global/en/products/cb/control-f-level- 3-bio-38101246.html ... Control F Level 3 Bio, for Cedex Bio and Cedex Bio HT Analyzers ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

52 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Molecular Partners AG

Allergan and Molecular Partners Present Late-Breaking Data from Pha...

... Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational ... SEQUOIA are identical global Phase 3 studies designed to assess the efficacy and safety of Abicipar 8-week ... the pooled Phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week ... Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational ... Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational ...

INTERIM MANAGEMENT STATEMENT – Q3 2019: Encouraging Additional Phas...

... phase 3 data, the proportion of patients with stable vision was 93%, 90% and 94% in 8-week abicipar, 12 ... Additional Phase 3 Data Presented for Abicipar, and Start of Phase 1 Trial for MP0310, the First Immuno ... INTERIM MANAGEMENT STATEMENT – Q3 2019: Encouraging Additional Phase 3 Data Presented for Abicipar, ... INTERIM MANAGEMENT STATEMENT – Q3 2019: Encouraging Additional Phase 3 Data Presented for Abicipar ... INTERIM MANAGEMENT STATEMENT – Q3 2019: Encouraging Additional Phase 3 Data Presented for Abicipar, ...

Mehr Ergebnisse

Kowa Pharmaceutical Europe AG

https://kowapharmaceuticals.eu/  

8952 Schlieren, Zürcherstrasse 39D

Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities. Kowa are committed to improving health standards in Europe and globally.

Kowa Pharmaceutical Europe AG

Zürcherstrasse 39D

8952 Schlieren

9 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Kowa Pharmaceutical Europe AG

Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01-3/DC

... Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01- 3/DC Kowa Pharmaceutical Europe GmbH ... Excipient(s) include252.34mg Lactose monohydrate. For the full list of excipients, see section 6.1. 3 ... Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01- 3/DC ... Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01- 3/DC Kowa Pharmaceutical Europe GmbH ... Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01- 3/DC ...

Initiation of Phase 3 clinical study in the United States Indicatio...

... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ... to initiate a Phase 3 study. This Substance was launched in December 2014 in Japan (Brand name ... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ...

Mehr Ergebnisse

Dualsystems Biotech AG

http://www.dualsystems.com  

8952 Schlieren, Grabenstrasse 11a

 +41 44 738 50 00
 info@dualsystems.com

Dualsystems Biotech is a provider of proteomics services for industry and academia.

Dualsystems Biotech AG

Grabenstrasse 11a

8952 Schlieren

278 Ergebnisse für "怎么查酒店开房信息- 查询微信90 3" unter Dualsystems Biotech AG

November 3 – Dualsystems Biotech

... November 3 – Dualsystems Biotech November 3 – Dualsystems Biotech Ligand-receptor capture ... technology LRC-TriCEPS on living cells BIO-Europe – Frankfurt, Germany, November 3 – November 5, 2014 BIO ... http://www.dualsystems.com/blog/tag/november- 3/feed/ ... November 3 – Dualsystems Biotech November 3 – Dualsystems Biotech Ligand-receptor capture ... November 3 – Dualsystems Biotech ...

November 3 Archives - Dualsystems Biotech

... Posts BIO–Europe  – Building value through partnerships, Frankfurt, Germany, November 3 – November ... , Germany, November 3 - November 5, 2014 Contact form +41 44 738 50 00 The TriCEPS™-based ligand-receptor ... http://www.dualsystems.com/blog/tag/november- 3/ ... November 3 Archives - Dualsystems Biotech Contact News-Event-Blog Meet Dr. Paul Helbling at BIO ... November 3 Archives - Dualsystems Biotech ...

Mehr Ergebnisse

Mehr Firmen

Nach oben